Published in
American Medical Association, JAMA Internal Medicine, 4(184), p. 341, 2024
DOI: 10.1001/jamainternmed.2023.7733
Links
Tools
Body Composition in Anti-Obesity Medication Trials—Beyond Scales
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 
Abstract
This Viewpoint contends that focusing only on weight loss as the primary weight medication end point is an inaccurate measure of medication efficacy for both patients and clinicians.